DUSA Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 12   

Articles published

DUSA 0.0000
price chart
Benefit of $4 bn Ranbaxy deal to accrue in few years: Sun Pharma
New Delhi: It will take a "few years" for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a "complex and large acquisition". Sun will leverage on complementary ...
Related articles »  
WeissLaw LLP Investigates Dusa Pharmaceuticals Inc